The Chinese Bioscience Association (CBA) is a non-profit organization founded in the San Francisco Bay area in 1997. Its mission is to promote education, networking and community building for life science professionals. Since its foundation, CBA has held hundreds of scientific conferences and workshops focusing on emerging trends and cutting-edge technologies in the biotech industry and attracted participants from entrepreneurs, C-level executives, managers, scientists, post-docs and students.

CBA currently has hundreds of active members and supporters ranging from CEOs, founders, business executives, professors, mid-level managers, scientists, students and postdocs. As a bi-lingual non-profit organization, CBA plays a key role to bridge the industry and cultural gaps between US and Asia, and has strong ties to Taiwan, China (including Hong Kong) and Singapore. Our annual conferences and summer picnics are especially popular with members, friends and family members. CBA is a volunteer organization supported generously by its sponsors and members.

HO Family Scholarship (CBA) is available thanks to the generosity of Ho family. Details can be found here and Application form here.


  • Moring Keynote speaker Dr. Lawrence Steinman (Professor, Stanford)
  • Afternoon Keynote speaker Dr. Michele Cleary (VP and Head, Bristol-Myers Squibb)
  • Dr. Betty Chang (VP, Pharmacyclics, an Abbvie Company)
  • Dr. Lawrence Gan (President and CEO, Development Center for Biotechnology, Taiwan)
  • Dr. Ruhong Jiang (Co-founder and CEO, Applied StemCell, Inc)
  • Dr. Jack Li (Associate Professor, University of San Francisco)
  • Dr. Cheng Liu (Founder & CEO, Eureka Therapeutics)
  • Dr. Henry Lu (VP, WuXi AppTec)
  • Dr. Yang Pan (Director of Biomarker Sciences, Gilead)
  • Dr. Juha Punnonen (Executive Director, Merck)
  • Dr. Stanley Qi (Assistant Professor, Stanford)


Active CBA members:
$20 online registration from Sept 19th to Oct 4th. Lunch included. Online registration closed.
$30 onsite. Lunch not guaranteed.

$45 online registration from Sept 19th to Oct 4th. Lunch included. Online registration closed.
$55 onsite. Lunch not guaranteed.

2016 CBA Annual Conference Agenda

(Conference Brochure)

8:30 – 9:00 am Registration, Networking & Exhibitions
9:00 – 9:05 am Welcome and Opening Remarks

Dr. Kai Zheng, 2016 CBA president

9:05 – 9:10 am Conference Introduction

Dr. Mark Chen, 2016 CBA Conference Chair

Session I: Therapeutic discovery

Moderator: Dr. Huifang Li

9:10 – 9:50 am Morning keynote presentation: Molecular guardians in inflammatory disease

Dr. Lawrence Steinman, Professor, Stanford University

9:50 – 10:20 am The landscape and capabilities of new drug discovery and development in Taiwan

Dr. Lawrence Gan, President and CEO, Development Center for Biotechnology

10:20 – 10:30 pm Networking & Exhibitions
10:30 – 11:00 am Genomics and translational science for drug discovery and clinical development

Dr. Henry Lu, Vice President, WuXi AppTec

11:00 – 11:30 am The development of ibrutinib, a first-in-class small molecule BTK inhibitor

Dr. Betty Chang, Vice President, Pharmacyclics

11:30 – 11:45 am

11:45 – 12:00 pm

Sponsor presentation by Merck, Simcere, and Gilead

Networking & Exhibitions

Lunch Session

Moderator: Dr. Patrick Yang

12:00 – 12:35 pm History of anti-ulcer drugs

Dr. Jack Li, Associate Professor, University of San Francisco

12:35 – 12:45 pm Ho Family Scholarship Award

Mr. Caesar Ho

12:45 – 1:00 pm Networking & Exhibitions

Session II: Translational Science

Moderator: Dr. Shian-Jiun Shih

1:00 – 1:40 pm Afternoon keynote presentation: Enabling drug development through translation Research

Dr. Michele Cleary, Vice President and Head, Bristol-Myers Squibb

1:40 – 2:10 pm Optimize biomarker strategy for clinical drug development

Dr. Yang Pan, Director of Biomarker Sciences, Gilead

2:10 – 2:25 pm Networking & Exhibitions

Session III              Immunotherapy

Moderator: Dr. Michelle Chen

2:25 – 2:55 pm The new era in immuno-oncology: anti-PD-1 and beyond

Dr. Juha Punnonen, Executive Director, Merck

2:55 – 3:25 pm New technologies in CAR-T therapy for treatment of solid tumors and reducing “Cytokine Storm”

Dr. Cheng Liu, Founder & CEO, Eureka Therapeutics

3:25 – 3:35 pm Networking & Exhibitions

Session IV: Panel Discussion

Moderator: Dr. Lin Sun-Hoffman

3:35 – 4:25 pm Gene editing: Science and legal stories behind CRISPR

Dr. Stanley Qi, Assistant Professor, Stanford University

Dr. Ruhong Jiang, Co-founder and CEO, Applied StemCell, Inc.

Dr. Lin Sun-Hoffman, J.D., President, Sun-Hoffman Consulting

4:25 – 4:30 pm Closing Remarks

Dr. Mark Chen, 2016 CBA Conference Chair

There will be a networking reception after the conference close in the Ultra Lounge at Crowne Plaza